Compare SLQT & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLQT | MBOT |
|---|---|---|
| Founded | 1999 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.6M | 166.6M |
| IPO Year | 2020 | 2000 |
| Metric | SLQT | MBOT |
|---|---|---|
| Price | $1.22 | $2.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $2.88 | ★ $7.50 |
| AVG Volume (30 Days) | 932.1K | ★ 1.4M |
| Earning Date | 05-05-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 105.00 | 60.27 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,526,594,000.00 | $116,887.00 |
| Revenue This Year | $10.97 | N/A |
| Revenue Next Year | $6.14 | $119.77 |
| P/E Ratio | $81.71 | ★ N/A |
| Revenue Growth | ★ 15.50 | N/A |
| 52 Week Low | $0.56 | $1.60 |
| 52 Week High | $2.80 | $4.62 |
| Indicator | SLQT | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 74.40 | 40.05 |
| Support Level | $0.81 | $1.99 |
| Resistance Level | $2.17 | $2.22 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 84.75 | 20.48 |
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.